ReoPro GPIIb/IIIa anti-platelet antibody data

CNTO announced that the EPILOG trial in 2,800 patients undergoing angioplasty

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE